Last updated on November 2019

PF-06741086 Long-term Treatment in Severe Hemophilia

---

Brief description of study

This study is designed to evaluate the safety, tolerability and efficacy of long-term treatment with PF-06741086 in subjects with severe hemophilia who participated in the 3-month Phase 1b/2 B7841002 study. Additionally, de novo subjects will be recruited into this study.